Beijing Konruns Pharmaceutical Co.,Ltd.

XSSC:603590 Stock Report

Market Cap: CN¥4.0b

Beijing Konruns PharmaceuticalLtd Future Growth

Future criteria checks 5/6

Beijing Konruns PharmaceuticalLtd is forecast to grow earnings and revenue by 34.3% and 24.1% per annum respectively. EPS is expected to grow by 33.9% per annum. Return on equity is forecast to be 7.9% in 3 years.

Key information

34.3%

Earnings growth rate

33.9%

EPS growth rate

Pharmaceuticals earnings growth19.4%
Revenue growth rate24.1%
Future return on equity7.9%
Analyst coverage

Low

Last updated14 Jun 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:603590 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,556295N/A4022
12/31/20251,283235N/A3392
12/31/20241,077186N/A3202
9/30/202484611549165N/A
6/30/2024874137132238N/A
3/31/2024954166126229N/A
12/31/202392015098199N/A
9/30/202399914667134N/A
6/30/20239461125197N/A
3/31/202387681-1077N/A
12/31/202286710123120N/A
9/30/202280111461201N/A
6/30/2022726130-38152N/A
3/31/2022755130-9682N/A
12/31/2021810148-10856N/A
9/30/2021855179-141-20N/A
6/30/2021916180-141-54N/A
3/31/2021949216-2428N/A
12/31/2020809183858N/A
9/30/202085520483119N/A
6/30/2020870220186208N/A
3/31/2020944249238255N/A
12/31/20191,066266243262N/A
9/30/20191,038311266285N/A
6/30/20191,029313303317N/A
3/31/2019982273308327N/A
12/31/2018973264246263N/A
9/30/2018897215250273N/A
12/31/2017591479N/A270N/A
12/31/2016346192N/A148N/A
12/31/2015436195N/A192N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603590's forecast earnings growth (34.3% per year) is above the savings rate (2.8%).

Earnings vs Market: 603590's earnings (34.3% per year) are forecast to grow faster than the CN market (26.5% per year).

High Growth Earnings: 603590's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 603590's revenue (24.1% per year) is forecast to grow faster than the CN market (14.1% per year).

High Growth Revenue: 603590's revenue (24.1% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603590's Return on Equity is forecast to be low in 3 years time (7.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y